upadacitinib

Ukraine

Drugs containing this active substance

  • RINVOK

    The drug is prescribed for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), atopic dermatitis, ulcerative colitis, and Crohn's disease.

    Form: tablets, film-coated, prolonged release

    Active substance Dosage
    upadacitinib 15 mg

    ATC: L04AF03

    Manufacturer: AbbVie S.r.l. (primary and secondary packaging, batch release)